Aplagon
Helsinki, FI · 7 known investors
Aplagon is a clinical-stage biopharmaceutical company developing first-in-class therapeutics targeting thromboinflammatory and cardiovascular diseases. The company's lead candidate, APAC, is a heparin proteoglycan mimetic currently in clinical trials.
BiotechHealthtechMedical Devices
Founders & leadership
SL
Sakari LassilainFounder
Investors · 7
Also in the syndicate · 4
European Innovation Council (EIC) FundleadFåhraeus Startup and Growth (FSG)leadGösta Serlachius Fine Arts FoundationJenny and Antti Wihuri Foundation
In the news
Frequently asked questions
- What does Aplagon do?
- Aplagon is a clinical-stage biopharmaceutical company developing first-in-class therapeutics targeting thromboinflammatory and cardiovascular diseases. The company's lead candidate, APAC, is a heparin proteoglycan mimetic currently in clinical trials.
- Who founded Aplagon?
- Aplagon was founded by Sakari Lassila.
- Who are Aplagon's investors?
- Aplagon's investors include FSG, Innovestor Ventures, Innovestor.
- Where is Aplagon headquartered?
- Aplagon is headquartered in Helsinki, FI.